Targeting COVID-19 Viral Enzymes in an Evolving Landscape of Publishing and Peer Review

12/5/2020; 66 minutes

UCSF scientists studying a key enzyme used by the virus that causes COVID-19 have identified chemical building blocks that might eventually be used to make an antiviral drug. The chemical fragments could bind to and disable the enzyme, called the "macro domain," which is a crucial part of the SARS-CoV-2 virus's ability to replicate in human cells. James Fraser discusses the finding from this research. Recorded on 12/02/2020. (#36500)

Links & Resources

 

SIGN UP FOR EMAIL UPDATES
Subscribe to receive email notifications about featured videos.
(c)2020 Regents of the University of California. All right reserved. Terms and Conditions of Use.